Summary of results in hemophilia B dogs after skeletal muscle delivery of AAV-canine FIX R338L
Dog . | Age/sex/weight . | Plateau cFIX expression . | Ratio activity/antigen* . | WBCT,† min . | Inhibitors . | IFN-γ ELISpot . | |||
---|---|---|---|---|---|---|---|---|---|
Activity, % . | Antigen, % . | AAV . | cFIX . | 338 peptides . | |||||
M55 | 7 mo/male/23 kg | 8 | 1.5 | 8.58 ± 0.46 | 11.4 ± 0.7 | ND | — | — | — |
M59 | 7 mo/male/16.5 kg | 3.5 | 0.35 | 9.24 ± 0.44 | 13.7 ± 0.7 | ND | ND | ND | ND |
N07 | 6 mo/male/13 kg | 5.5 | 0.65 | 9.0 ± 0.37 | 14.4 ± 0.7 | ND | ND | ND | ND |
Dog . | Age/sex/weight . | Plateau cFIX expression . | Ratio activity/antigen* . | WBCT,† min . | Inhibitors . | IFN-γ ELISpot . | |||
---|---|---|---|---|---|---|---|---|---|
Activity, % . | Antigen, % . | AAV . | cFIX . | 338 peptides . | |||||
M55 | 7 mo/male/23 kg | 8 | 1.5 | 8.58 ± 0.46 | 11.4 ± 0.7 | ND | — | — | — |
M59 | 7 mo/male/16.5 kg | 3.5 | 0.35 | 9.24 ± 0.44 | 13.7 ± 0.7 | ND | ND | ND | ND |
N07 | 6 mo/male/13 kg | 5.5 | 0.65 | 9.0 ± 0.37 | 14.4 ± 0.7 | ND | ND | ND | ND |